Evidence map›Paper›PMID 41721016›Full record

ArticleNature chemistry2026

Catalytic asymmetric sulfonimidoyl transfer to access chiral sulfonimidoyl fluorides and related derivatives.

Ning Li, Sai-Ya Lian, Tao Wei, Wen-Jing Li, Jun-Hao Zhang, Dong-Chao Wang, Yin Tian, Ming-Sheng Xie, Hai-Ming Guo

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Iron-Catalyzed Asymmetric NHAngewandte Chemie (International ed. in English) · 2026
    Article
  3. Article
  4. High-Fidelity Transfer of Chiral Sulfonimidoyl Radicals.Journal of the American Chemical Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ning LiState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, China.
Sai-Ya LianState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, China.
Tao WeiState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, China.ORCID http://orcid.org/0009-0005-3998-4101
Wen-Jing LiState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, China.
Jun-Hao ZhangState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, China.
Dong-Chao WangState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, China.
Yin TianState Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China. ytian227@outlook.com.ORCID http://orcid.org/0000-0001-7039-0479
Ming-Sheng XieState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, China. xiemingsheng@htu.edu.cn.ORCID http://orcid.org/0000-0003-4113-2168
Hai-Ming GuoState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, China. ghm@htu.edu.cn.ORCID http://orcid.org/0000-0003-0629-4524

Funding

National Natural Science Foundation of China (National Science Foundation of China) NSFC (22422103)National Natural Science Foundation of China (National Science Foundation of China) NSFC (U22A20378)
6 · The paper itself

Abstract

Sulfur fluoride exchange (SuFEx) click chemistry is a powerful tool for constructing functional molecules. However, catalytic asymmetric methods for constructing chiral sulfur(VI)-centred sulfonimidoyl fluorides are rare, resulting in the limited application of SuFEx. Owing to the crowded three-dimensional environment, chiral sulfonimidoyl transfer is challenging. Here we show a catalytic enantioselective Cl-F exchange reaction to realize the asymmetric sulfonimidoyl transfer reaction with racemic sulfonimidoyl chlorides as reactants, constructing chiral SuFEx connecting arms. This strategy enables chiral sulfonimidoyl azides, sulfonimidamides and sulfonimidoyl esters by reacting with corresponding nucleophiles. Mechanistic studies revealed that the reaction is a dynamic kinetic asymmetric transformation process, and a two-catalyst-bound pentacoordinate sulfur is responsible for the sulfur-configurational epimerization. The key steps involve the formation of O-sulfonimidoyl ester pyridinium cation intermediates via covalent organocatalysis. The resulting optically active sulfonimidoyl fluorides enable a further stereospecific SuFEx with C-, N- and O-centred nucleophiles, thereby establishing a modular platform for the asymmetric SuFEx ligation.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.